These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28565743)

  • 1. [Distribution of donor-specific aKIR after unrelated allogeneic hematopoietic stem cell transplantation].
    Zhang HH; He J; Bao XJ; Hu X; Wang M; Zhang J; Wu XJ
    Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):421-426. PubMed ID: 28565743
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic mRNA expression of donor-derived activating KIR genes and their significant effects on clinical outcome after haematopoietic stem cell transplantation.
    Li Y; Wang T; Hu X; Zhang H; Bao X; Wu D; He J
    Clin Exp Immunol; 2021 Sep; 205(3):417-428. PubMed ID: 34085290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma.
    Barani S; Taghipour M; Ghaderi A
    Immunobiology; 2020 Mar; 225(2):151900. PubMed ID: 31899050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.
    Crum KA; Logue SE; Curran MD; Middleton D
    Tissue Antigens; 2000 Oct; 56(4):313-26. PubMed ID: 11098931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of KIR gene expression at the mRNA level in specific donor-derived NK cells after allogeneic HSCT.
    Li Y; Wang T; Hu X; Zhang H; Chen L; Bao X; He J
    Immunogenetics; 2020 Apr; 72(3):135-141. PubMed ID: 31900503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune reconstruct regularity profile of KIR2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation].
    Hu X; He J; Zhang HH; Bao XJ; Wang M; Zhang J; Cen JN; Wu XJ; Yang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):667-672. PubMed ID: 28954344
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
    Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism analysis of killer cell immunoglobulin-like receptor genes in the Chinese Uygur population.
    Wang HD; Zhu BF; Shen CM; Yuan GL; Yang G; Guo JN; Yan JW; Qin HX; Guo JX; Zhang LP; Jia XQ; Lucas R
    Mol Biol Rep; 2012 Mar; 39(3):3017-28. PubMed ID: 21701829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
    Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
    N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].
    Liang ZY; Ren HY; Cen XN; Qiu ZX; Wang LH; Ou JP; Li Y; Wang MJ; Wang WS; Xu WL; Dong YJ; Yin Y; Sun YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):155-60. PubMed ID: 23484711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Killer immunoglobulin-like receptor gene genotype and expression pattern in healthy people].
    Dou LP; DA WM; Huang WR; Li HH; Zhao Y; Wang QS; Gao CJ; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):132-5. PubMed ID: 20137133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
    Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
    Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell Transplantation.
    Planelles D; Vilches C; González-Escribano F; Muro M; González-Fernández R; Sánchez F; Gonzalo Ocejo J; Eiras A; Caro JL; Palou E; Campillo JA; de Juan MD; Montes O; Balas A; Marín L; Torío A; Fernández-Arquero M; González-Roiz C; López-Vázquez A; Cisneros E; Abad-Molina C; López R; Abad-Alastruey ML; Serra C; García-Alonso AM; Vicario JL
    Transplant Proc; 2016 Nov; 48(9):3043-3045. PubMed ID: 27932143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
    Contreras G; Aláez C; Murguía A; García D; Flores H; Gorodezky C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Killer Immunoglobulin-Like Receptor Profile Bx1 Imparts a Negative Effect and Centromeric B-Specific Gene Motifs Render a Positive Effect on Standard-Risk Acute Myeloid Leukemia/Myelodysplastic Syndrome Patient Survival after Unrelated Donor Hematopoietic Stem Cell Transplantation.
    Bao X; Wang M; Zhou H; Zhang H; Wu X; Yuan X; Li Y; Wu D; He J
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):232-239. PubMed ID: 26371372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the killer-cell immunoglobulin like receptor polymorphism in retinoblastoma.
    Aggarwal R; Sharma M; Singh U; Poulton K; Bhatia T; Mangat N; Kakkar N; Bansal D
    Ophthalmic Genet; 2023 Feb; 44(1):1-5. PubMed ID: 36594723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.